{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02854579",
      "OrgStudyIdInfo": {
        "OrgStudyId": "NavyGHB-P-01"
      },
      "Organization": {
        "OrgFullName": "Navy General Hospital, Beijing",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy",
      "OfficialTitle": "Safety and Efficacy Study of Neural Progenitor Cell Transplantation and Paracrine Factors From Human Mesenchymal Stem Cells to Treat Newborn With Hypoxic-ischemic Encephalopathy"
    },
    "StatusModule": {
      "StatusVerifiedDate": "July 2016",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "July 2017",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2017",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "April 27, 2014",
      "StudyFirstSubmitQCDate": "July 30, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 3, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "July 30, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 3, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Zuo Luan",
        "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
        "ResponsiblePartyInvestigatorAffiliation": "Navy General Hospital, Beijing"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Navy General Hospital, Beijing",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Bethune International Peace Hospital",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Hunan Children's Hospital",
            "CollaboratorClass": "OTHER_GOV"
          },
          {
            "CollaboratorName": "Shangluo Central Hospital",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "252 Military Hospital",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to investigate the efficacy and safety of allogenic neural progenitor cell and paracrine factors of human mesenchymal stem cells for patients with moderate/severe Hypoxic-Ischemic Encephalopathy",
      "DetailedDescription": "Neonates diagnosed moderate/severe Hypoxic-Ischemic Encephalopathy after birth will receive routine therapy and be randomized to four arms for allogenic neural progenitor cells transplantation，paracrine factors of human mesenchymal stem cells intrathecal injection，combination of cell and factor or only routine therapy. Patients will be followed for neurodevelopmental outcome at 12 and 18 months in Pediatrics of Navy General Hospital. Magnetic Resonance Imaging, electroencephalogram, Bailey scores, Peabody development measure scale and Gross motor function measure assessment will be obtained in the following research.Results will be analyzed and described in study reports."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Hypoxic-Ischemic Encephalopathy"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Hypoxic-Ischemic Encephalopathy",
          "progenitor cell",
          "paracrine factor",
          "adipose mesenchymal stem cell",
          "neonate"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "120",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Neural progenitor cell",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Three doses of Neural progenitor cell (4*10^6) intrathecally at 48-72h, 5d and 10d after birth.+routine therapy",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: neural progenitor cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "Paracrine factors",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Three doses of concentrated paracrine factors of human mesenchymal stem cell （0.5ml） intrathecally at 12h,24h,48h after birth.+routine therapy",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Paracrine factors"
              ]
            }
          },
          {
            "ArmGroupLabel": "Progenitor cell and paracrine factors",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Three doses of concentrated paracrine factors 0.5ml intrathecally at 12h,24h,48h after birth.And three doses of neural progenitor cell (4*10^6) intrathecally at 48-72h, 5d and 10d after birth.+routine therapy",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: progenitor cell and paracrine factors"
              ]
            }
          },
          {
            "ArmGroupLabel": "Routine therapy",
            "ArmGroupType": "No Intervention",
            "ArmGroupDescription": "neonates only receive routine therapy"
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "neural progenitor cell",
            "InterventionDescription": "Neural progenitor cells are derived from the same aborted human fetal forebrain.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Neural progenitor cell"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Paracrine factors",
            "InterventionDescription": "The factors obtained from cultured human mesenchymal stem cells were concentrated 50 times",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Paracrine factors"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "paracrine factor of human mesenchymal stem cells"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "progenitor cell and paracrine factors",
            "InterventionDescription": "Neural progenitor cells will be received after paracrine factors therapy",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Progenitor cell and paracrine factors"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Neonatal Behavioral Neurological Assessment",
            "PrimaryOutcomeTimeFrame": "14days after birth"
          },
          {
            "PrimaryOutcomeMeasure": "number of adverse events",
            "PrimaryOutcomeDescription": "adverse events like fever、infection、seizures、hemorrhage coursed by interventions",
            "PrimaryOutcomeTimeFrame": "7days after cell or factor injection"
          },
          {
            "PrimaryOutcomeMeasure": "Neonatal Behavioral Neurological Assessment",
            "PrimaryOutcomeTimeFrame": "28days after birth"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Bayley score",
            "SecondaryOutcomeDescription": "Gross motor function measure assessment for children diagnosed cerebral palsy",
            "SecondaryOutcomeTimeFrame": "12 months after birth"
          },
          {
            "SecondaryOutcomeMeasure": "Bayley score",
            "SecondaryOutcomeDescription": "Gross motor function measure assessment for children diagnosed cerebral palsy",
            "SecondaryOutcomeTimeFrame": "18 months after birth"
          },
          {
            "SecondaryOutcomeMeasure": "Peabody development measure scale",
            "SecondaryOutcomeDescription": "Gross motor function measure assessment for children diagnosed cerebral palsy",
            "SecondaryOutcomeTimeFrame": "12 months after birth"
          },
          {
            "SecondaryOutcomeMeasure": "Peabody development measure scale",
            "SecondaryOutcomeDescription": "Gross motor function measure assessment for children diagnosed cerebral palsy",
            "SecondaryOutcomeTimeFrame": "18 months after birth"
          },
          {
            "SecondaryOutcomeMeasure": "Number of death",
            "SecondaryOutcomeTimeFrame": "1 years after birth"
          },
          {
            "SecondaryOutcomeMeasure": "Number of participants with treatment-related central nervous tumor as assessed by Magnetic Resonance Imaging or CT",
            "SecondaryOutcomeTimeFrame": "5 years after birth"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\ngestational age ≥ 34weeks, body weight ≥ 2kg.\n1 minute apgar score ≤3, and 5 minutes apgar score ≤5, OR umbilical arterial blood gas potential of hydrogen<7.0, OR 30 minutes base excess≤-12 mmol/L, OR need for ventilation 5 minutes after birth.\nAll infants must have signs of encephalopathy (such as convulsion, coma, dystonia, abnormal primitive reflex and irregular respiration) within 6 hours of age or continued abnormal EEG for more than 24h.\n\nExclusion Criteria:\n\nDoes not meet the inclusion criteria\nSuffer from other serious organic disease or congenital, hereditary metabolic diseases\nIntracranial active infection, or neuromuscular damage outside central nervous system\npotential of hydrogen / electrolyte disorders without improvement or stability\nCoagulation disorders associated with bleeding tendency\nImmune function is not perfect\nPatients or his guardian refuse consent.\nPatients or his guardian don't accept the follow-up schedule.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MaximumAge": "14 Days",
      "StdAgeList": {
        "StdAge": [
          "Child"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Zuo Luan, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "18600317210",
            "CentralContactEMail": "hjzyyerke@163.com"
          },
          {
            "CentralContactName": "Weipeng Liu, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "13581797015",
            "CentralContactEMail": "hjzyynicu@163.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Zuo Luan, MD",
            "OverallOfficialAffiliation": "Navy General Hosiptal",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Navy General Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Beijing",
            "LocationState": "Beijing",
            "LocationZip": "100048",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Zuo Luan, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactEMail": "hjzyyerke@163.com"
                },
                {
                  "LocationContactName": "Zuo Luan, MD",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Weipeng Liu, MD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "Navy General Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Beijing",
            "LocationZip": "100048",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Zuo Luan, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "18600310270",
                  "LocationContactEMail": "hjzyyerke@163.com"
                },
                {
                  "LocationContactName": "Weipeng Liu, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "135581797015",
                  "LocationContactEMail": "hjzyynicu@163.com"
                },
                {
                  "LocationContactName": "Zuo Luan, MD",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Weipeng Liu, MD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "22507684",
            "ReferenceType": "background",
            "ReferenceCitation": "Luan Z, Liu W, Qu S, Du K, He S, Wang Z, Yang Y, Wang C, Gong X. Effects of neural progenitor cell transplantation in children with severe cerebral palsy. Cell Transplant. 2012;21 Suppl 1:S91-8. doi: 10.3727/096368912X633806."
          },
          {
            "ReferencePMID": "32813884",
            "ReferenceType": "derived",
            "ReferenceCitation": "Bruschettini M, Romantsik O, Moreira A, Ley D, Thébaud B. Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants. Cochrane Database Syst Rev. 2020 Aug 19;8:CD013202. doi: 10.1002/14651858.CD013202.pub2."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000001927",
            "ConditionMeshTerm": "Brain Diseases"
          },
          {
            "ConditionMeshId": "D000002545",
            "ConditionMeshTerm": "Brain Ischemia"
          },
          {
            "ConditionMeshId": "D000020925",
            "ConditionMeshTerm": "Hypoxia-Ischemia, Brain"
          },
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          },
          {
            "ConditionMeshId": "D000000860",
            "ConditionMeshTerm": "Hypoxia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000002493",
            "ConditionAncestorTerm": "Central Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000012818",
            "ConditionAncestorTerm": "Signs and Symptoms, Respiratory"
          },
          {
            "ConditionAncestorId": "D000002561",
            "ConditionAncestorTerm": "Cerebrovascular Disorders"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000002534",
            "ConditionAncestorTerm": "Hypoxia, Brain"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemic",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3337",
            "ConditionBrowseLeafName": "Hypoxia",
            "ConditionBrowseLeafAsFound": "Hypoxic",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M4946",
            "ConditionBrowseLeafName": "Brain Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemic Encephalopathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M4356",
            "ConditionBrowseLeafName": "Brain Diseases",
            "ConditionBrowseLeafAsFound": "Encephalopathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21813",
            "ConditionBrowseLeafName": "Hypoxia-Ischemia, Brain",
            "ConditionBrowseLeafAsFound": "Hypoxic Ischemic Encephalopathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M4894",
            "ConditionBrowseLeafName": "Central Nervous System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14775",
            "ConditionBrowseLeafName": "Signs and Symptoms, Respiratory",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4962",
            "ConditionBrowseLeafName": "Cerebrovascular Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4935",
            "ConditionBrowseLeafName": "Hypoxia, Brain",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          }
        ]
      }
    }
  }
}